The application of diagnosis and treatment of Angiopoietin and Ephrin from retinal ischemia in the angiogenesis
The application of diagnosis and treatment of Angiopoietin and Ephrin from retinal ischemia in the angiogenesis
批准号:
12671696
负责人:
KISHI Shouji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
血管生成通过视网膜血管的循环障碍导致视网膜缺血。许多细胞因子,如血管内皮细胞生长因子,似乎与血管生成有关。为诱导视网膜缺血继发红斑和新生血管形成,用激光光凝结扎3只日本猴6只眼的视网膜主干静脉。光凝后1周、2周、4周分别摘除2只红斑眼和新生血管眼。采用免疫组织化学方法,对虹膜、小梁和视网膜新生血管石蜡切片进行免疫组织化学染色。治疗后1周、2周、4周小梁网和Schlemms管均呈阳性染色,抗体定位采用氨乙基卡巴唑显色法。治疗后2周和4周的切片中,ewitin-B2呈阳性表达,而在1周的切片中表达不明确。在所有切片中,ePhrin-B4和Angiopoietin-2的表达均不显著。治疗后1、2、4周所有视网膜新生血管均呈VEGF阳性表达。其中1例治疗后仅2周切片中EPhin-B2、B4、Angiopoietin-2呈阳性表达,另1例未见EPhin-B4、Angiopoietin-2阳性表达。在一周和四周的时间里,这两个部分的情况都不确定。在实验性红斑病和新生血管形成中,血管内皮生长因子的表达紧随其后的是EPhin-B2的表达。这些数据提示,动脉分化过程中EPhin-B2的表达可能在新生血管的生长过程中起作用。
英文摘要
Angiogenesis produces retinal ischemia by circulatory disturbance of retinal vessel. Many cytokines such as vascular endothelial grouth factor (VGEF) seem to be related to the angiogenesis. In order to induce rubeosis and neovascularization secondary to retinal ischemia, major retinal veins were occluded with laser photocoagulation in 6 eyes of 3 Japanese monkeys. Two eyes with rubeosis and neovascularization were enucleated one week, two weeks and four weeks respectively after photocoagulation. Immunohistochemical analysis was performed on fixed paraffin sections of the iris, trabeculum and retinal neovascularization using polyclonal antibody against Ephrin-B2, Eph-B4, Angiopoietin-2 and VEGF. Antibody localization was examined using anavidin-biotin reaction linked to aminoethylcarbabazole color reagent the trabecular meshwork and the Schlemms canal including 1, 2 and 4 weeks after treatment, showed positive staining for VEGF. Ephrin-B2 was positively stained in the section of 2 and 4 weeks after treatment but it was uncertain in the sections of one week. Ephrin- B4 and Angiopoietin-2 were not significant in any sections. All retinal neovascularization 1, 2 and 4 weeks after treatment, showed positive staining for VEGF. One case, Ephrin-B2, B4 and Angiopoietin-2 were positively stained in the section for only 2 weeks after treatment, but other case was uncertain for Ephrin- B4 and Angiopoietin-2. It was uncertain in the sections for one and four weeks. Expression of VEGF was followed by that of Ephrin-B2 in experimentally induced rubeosis and neovasucularization. The data suggests the expression of Ephrin-B2, an arterial differentiation, might play a role in grouth of newly formed vessels.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Takashi Yuki,Yasutaka Kimura Tsugiyasu Kanda etc: "Expression of Ephrins in iris rubeosis in primates eyes"Investigative Ophthalmology and Visual Science. 41・4. 8507 (2000)
Takashi Yuki、Yasutaka Kimura Tsugiyasu Kanda 等:“灵长类动物眼睛虹膜红肿中 Ephrins 的表达”调查眼科和视觉科学 41・4(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
The role of Activin-Follistatin System in Diabetic Retinopathy
-
批准号:20592032
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:KISHI Shouji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: